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Abstract  
Chronic atrophic gastritis (CAG) characterized by chronic inflammation of gastric mucosa with loss of gastric 
glandular cells and replacement by intestinal-type epithelium and fibrous tissue. CAG may be associated with 
Helicobacter pylori infection. The main Objective was to determine the role of FAS-FASL apoptotic pathway 
in H.pylori CagA positive associated chronic atrophic Gastritis .Forty five CAG patients and (20) control were 
chosen. Multiple gastric mucosal biopsies taken for rapid urease test and slides preparation from paraffin 
blocks. Biotinylated DNA probe for human FAS, FASL, genes used for detection of their expression in tissue 
lymphocytes and gastric epithelial cells using ISH technique. Biotinylated DNA probe for H.pylori Cag A 
gene used for detection of its expression in gastric epithelial cells. Insitu CagA was detected in (46.66%) of 
CAG cases. The toxin was not detected among control .Tissue FAS mRNA expression was higher than 
lymphocytes FAS mRNA among CagA positive and CagA negative CAG cases. Tissue infiltrating 
lymphocytes (TILs) FAS expression was higher among Cag Apositive than Cag A negative CAG cases. 
Significant difference in FASL mRNA   between Gastroduodenal tissue (GDT) and TILs among Cag A 
positive and Cag A negative CAG cases was detected. Lymphocyte grade has significant positive correlation 
with tissue FAS mRNA expression (p=0.005).Tissue FAS mRNA expression has significant positive 
correlation with CagA (p=0.000). Lymphocyte FAS mRNA expression has significant positive correlation 
with lymphocyte FASL mRNA expression (p=0.03) and CagA (p=0.000) .Tissue FasL has significant 
negative correlation with CagA (p=0. 001). Lymphocyte FASL mRNA expression has significant positive 
correlation with CagA (p=0.008).In Conclusions, FAS-FASL pathway play vital role in Immunopathology of 
H.pylori Cag A+ associated gastritis that leads finally to atrophic changes. 
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Introduction: 
Chronic Atrophic gastritis (CAG) is a histopathological entity characterized by chronic inflammation of the 
gastric mucosa with loss of gastric glandular cells and replacement by intestinal-type epithelium and fibrous 
tissue. CAG may be associated with Helicobacter pylori infection as well as unidentified environmental factors 
and autoimmunity directed against gastric glandular cells (1) .Apoptosis, programmed cell death, is essential in 
development and homeostasis of multicellular organisms. In addition, it may also serve as a defense mechanism 
against bacterial and viral infections (2). Apoptosis can be mediated through activation of the CD95 receptor 
(CD95) (APO-1/Fas) and ligand system (3). There is an evidences of possible relationship among the 
development of  atrophic  gastritis and the apoptotic process  that takes place in the epithelial cells of  stomach 
and duodenum ( 4).during the disease process there is an imbalance between epithelial cell proliferation and 
death from apoptosis ,thus disregulating the normal cell cycle and initially lead to gastritis ,and this may become 
gastric atrophy ,and then subsequently metaplasia,dysplasia and even  cancer (4,5 ). Helicobacter pylori 
(H.pylori) is considered as an important etiologic factor in the development of chronic gastritis and ulcer disease 
(6,7) . In toxigenic H. pylori–induced chronic gastritis, surface epithelial damage, erosions, and atrophy of the 
gastric mucosa as well as increased epithelial proliferation are striking histological features. Epithelial 
proliferation does not seem to be counterbalanced by epithelial necrosis in H. pylori– induced gastritis 
suggesting that apoptosis may account for the apparent cell loss in chronic gastritis (8) .In biopsies  taken from 
patients with H. pylori–associated  chronic atrophic gastritis ,duodenal ulcer, apoptosis of gastric epithelium was 
increased and involved upregulation of CD95 expression in surface epithelium, lamina propria lymphocytes, and 
pyloric gland cells and increase in CD95L expression in lymphocytes and gastric epithelial cells (4, 9 ). The 
main Objective was to determine the role of FAS-FASL Apoptotic pathway in H.pylori CagA positive associated 
chronic atrophic gastritis. 
   Materials and methods  
   2.1. Patients:  
The subjects of the present study selected from Patients attending the gastroenterology unit of digestive and 
hepatic diseases teaching hospital in Baghdad. Ethics committee of Diyala University, college of Medicine, 
approved the present study. At first the  aim  of  study  was explained  for all participants   and   after  obtaining 
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their  oral  consent they have been studied .The subjects were diagnosed as having atrophic gastritis by upper 
gastrointestinal endoscopy from May 2009 to December 2010.Forty five patients suffering from chronic atrophic 
gastritis were chosen. Twenty apparently healthy volunteers enrolled as control. 
 
2.2. Exclusion criteria used in the study  
Patients who had undergone or were currently undergoing H.pylori eradication therapy, Patients who had 
received antiulcer treatment in the last three months , and still receiving proton-pump inhibitors (PPI) or H 2 
receptor blockers. Patients who had received nonsteroidal anti-inflammatory drugs (NSAIDs) within two months 
before the examination. The result of rapid urease test was negative; all were excluded from investigation (10).  
 2.3. Sample collection:  
 Patients were fasted for at least eight hours before endoscopic examination. Endoscopic examination   
performed under local pharyngeal anesthesia. Using fiber optic endoscope, multiple mucosal biopsy specimens 
taken via sterile standard biopsy forceps from the stomach (inflamed area of gastric mucosa).  One-biopsy 
specimens used for rapid urease test (RUT) for detection of H.pylori in tissue sample. Other biopsy specimen 
used for gram stain. Rest biopsy specimens fixed with 10% buffered formalin for preparation of paraffin 
embedded tissue blocks to prepare slides for histological examination using haematoxylin-eosin. Biopsy 
specimens obtained from the antrum used to evaluate the grades of lymphocytes infiltration. The presence of 
H.pylori in tissue section was established by typical appearance on scanning along the mucosal surface and the 
individual gastric pits (10). 
 2.4.DNA Probes and DNA Probe hybridization/Detection System :  
a)Biotinylated long DNA probe for human Fas Gene, Cat. No.: IH-60047(fas-6001-B). (Maxim biotech-USA);b) 
Biotinylated long DNA probe for human FasL gene, Cat. No. IH-60031) (Maxim biotech-USA).c) Biotinylated 
long DNA probe for H.pylori/ Cag A Gene, Cat. No.: IH-60061(HPY-6001-B) (Maxim biotech-USA).d) The 
DNA Probe hybridization/Detection System – In Situ Kit (Maxim biotech-USA). 
2.5. Biopsy urease test (BUT):   
     The biopsies were placed directly into the rapid urea medium at the time of endoscopy. Positive results 
indicated by development of a pink-red or red-violet color (11).   
2.6. Insitu hybridization procedure  
    Human (Fas and  FasL) gene as well as  Cag A gene expression  for H.pylori   were detected in 4-6 µm thickness 
serial gastric mucosal tissue sections fixed on  positively charged slides .According to Maxim biotech instruction 
manual (12). The examination and scoring were done under light microscope by a pathologist at power X400 
according to the scoring system used by (10) in which negative results considered if less than 5% of examined cells 
were positive. low positive score was considered if 5-25% of examined cells were positive. Intermediate positive 
score considered if 26-50% of examined cells were positive. High positive score considered if >50% of examined 
cells were positive. 
2.7. Scoring system for lymphocytes (13) 
 Lymphocyte infiltration: Grading scale from 0 to 3, based on both lymphocyte and plasma cell infiltration. Grade 
0 considered if normal cellular finding detected. Grade 1 considered if in case of low inflammation, Grade 2 for 
Moderate inflammation and Grade 3 indicate heavy inflammation. 
3. Statistical analysis:  
 Data analysis performed using the following tests:  
 1. T-test used to find out the significance of differences between two groups that composed from continuous 
variables.  
2. Pearson test for correlation used for non-categorical data. The level of significance was 0.05(two-tail) in all 
statistical testing; significant of the level of confidence limits was 0.095.Statistical analysis performed using SPSS 
for windows TM version 14.0, and Microsoft EXCEL for windows 2007.  
Results:  
      Forty five  patients diagnosed endoscopically and histopathologically have CAG with the mean age 
(39.26±17.03) years were enrolled in the present study. CAG detected in (73.3%) of males versus (26.7%) among 
female as shown in table (1) . As shown in table (2) and figure (1 -A), Insitu CagA Cytotoxin   detected in 
21(46.66%) out of 45.The toxin was not detected among control cases.  In situ FAS mRNA expression level 
evaluated by using certain scoring system. Positive expression of FAS mRNA defined as expression in 5% or more 
of GDT. Positive expression of tissue FAS mRNA was detected in 21/45 case of CagApositive CAG (46.66%).Tissue 
expression of Fas mRNA was more than 50% in 9/45 (20%) of CagApositive CAG cases. Among CagAnegative tissue 
expression of Fas mRNA was more than 50% in 12/45 (26.66%). Intermediate expression   of tissue Fas mRNA 
was identical in both CagApositive+ and CagAnegative CAG cases in which 12(26.66%) out of 45 case gave same score 
of expression. Expression of lymphocyte Fas mRNA was more than 50% in 6/45 (13.33%) of CagApositive CAG 
cases. Intermediate expression of lymphocyte Fas mRNA was detected in 12 /45 (26.66%) of CagApositive CAG 
cases compared with 9/45 (20%) of CagA negative cases. Up to (70%)of  normal control cases tissue  Fas mRNA 
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expression  was negative and only in (30%) of cases low level of expression was detected on the other hand no 
detectable level of  Fas mRNA expression was found regarding to lymphocytes. Details of tissue Fas mRNA 
expression and scoring system was explained in table (3) and figure(1-C).Based on T-test, there is a significant 
differences between GDT and TILs (p<0.05 ) in FAS mRNA  expression among  cag A positive  and cag A negative  
CAG cases . There is a significant difference between Cag positive and Cag A negative Cases regarding over expression 
of tissue FAS mRNA (p<0.05) as shown in table (4)  
         In the present study we investigate in situ FASL mRNA expression in 45 cases of CAG. In situ FASL mRNA 
expression level evaluated by using certain scoring system .Figure (1-D) shows the typical in situ staining for 
tissue FASL mRNA. Less than 5%of stained cells considered negative for CAG cases. All other percentage of 
expression considered positive .positive expression of FASL mRNA defined as expression in 5% or more of GDT. 
Positive expression of tissue FASL mRNA was detected in 21/45case of Cag A positive CAG (46.66%).Tissue 
expression  of FasL mRNA was more than 50% in 3/45 (6.66%) of Cag A negative CAG cases compared with Cag A 
positive cases in which high level of expression was not detected. details of expression were explained in were 
explained in table (5).Based on T-test , significant differences in FASL mRNA  expression between GDT and TILs 
among  Cag A positive  as well as Cag A negative cases .There was no significant difference between Cag A positive and 
Cag A negative Cases regarding tissue FASL mRNA over expression (p>0.05) as shown in table(6). Comparative 
evaluation of FasL mRNA expression in GDU,CAG and control  group we found that there is a significant 
differences between control group and  H.pylori Cag Apositive CAG regarding tissue expression of FasL mRNA  (p 
<0.05 ) .Significant differences between control group and  H.pylori CagAnegative CAG regarding tissue expression 
of FasL mRNA  (p <0.05) as shown in table (6).  
      As shown in tables (7) Lymphocyte grade has significant strong positive correlation with tissue FAS mRNA 
expression (r= 0. 409, p=0.005) .tissue FAS mRNA expression has significant strong positive   correlation with 
CagA  (r= 0.540, p=0.000) . Lymphocyte FAS mRNA expression has significant strong positive correlation with 
lymphocyte FASL mRNA expression (r= 0. 310, p=0.03) and CagA (r= 0.511, p=0.000) .Tissue FasL has 
significant strong negative correlation with CagA( r= -0.484, p=0. 001). Lymphocyte FASL mRNA expression has 
significant strong positive correlation with CagA (r= 0.390,p=0.008). 
 
Table (1):  patients’  and Control Group Demography 
 
Subjects demography Clinical presentation 
CAG Control 
Age Minimum 18 23 
Maximum 75 58 
Mean± SD 39.26 ± 17.03 38 ± 10.89 
Gender Male 33 (73.3%) 10(50%) 
Female 12(26.7%) 10(50%) 
Total No. 45(100%) 20( 100% ) 
SD: Standard deviation 
Table (2): Frequency distribution of Insitu CagA Cytotoxin among CAG cases versus control 
 
Clinical presentation Insitu Cag A detection 
Positive Negative Total 
CAG 21(46.66%) 24 (53.33%) 45 
Control 0(0%) 10(100%) 10 
 
Table (3):  Frequency distribution of tissue versus lymphocytes insitu expression of FAS mRNA in Cag A    
positive/Cag A negative CAG Patients 
CagA 
In situ 
Marker 
CD95(APO1/FAS) 
Negative Positive Total No. 
Grade Grade 
Low Intermediate High 
<  5% 5-25% 26-50% >50% 
Cag positive Tissue FAS 0(0%) 0(0%) 9(20%) 12(26.66%) 21(46.66%) 
Lymphocyte FAS 0(0%) 3(6.66%) 12(26.66%) 6(13.33%) 
Cag negative Tissue FAS 0(0%) 3(6.66%) 15(33.34%) 6(13.33%) 24(53.33%) 
Lymphocyte FAS 0(0%) 15(33.34%) 9(20%) 0(0%) 
Control Tissue FAS 14(70%) 6(30%) 0(0%) 0(0%) 20 
(100%) Lymphocyte FAS 0(0%) 0(0%) 0(0%) 0(0%) 
Total no of CAG cases 45(100%) 
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Table (4):  Tissue versus lymphocytes insitu expression of FAS mRNA   in Cag Apositive/Cag Anegative CAG 
Patients. 
 
Marker 
CD95(APO1/FAS) 
Cag A 
Positive 
Cag A 
Negative 
Total 
No. 
T-test 
P value 
Tissue FAS 
mean ± SE* 
21(46.66%) 
66±3.45 
24(53.33%) 
45.62±3.45 
45 P<0.05 
 
Lymphocyte FAS 
mean ± SE* 
21(46.66%) 
38.57±6.28 
24(53.33%) 
22±6.2 
45 P<0.05 
 
T-test (p- value) P<0.05 
 
P<0.05 
 
 
Table (5): Frequency and distribution of tissue versus lymphocytes insitu expression of     FASL mRNA   
according to scoring system in Cag Apositive/ Cag A negative CAG Patients. 
CagA 
In situ 
hybridization 
Marker 
CD95L(FASL) 
 
Negative Positive 
Total  No. Grade Grade Low Intermediate High 
<  5% 5-25% 26-50% >50% 
Cag Apositive Tissue FASL 0(0%) 15(33.33%) 6(13.33%) 0(0%) 21(46.66%) Lymphocyte FASL 0(0%) 0(0%) 6(13.33%) 15(33.33%) 
Cag A negative 
Tissue FASL 3(6.66%) 9(20%) 9(20%) 3(6.66%) 
24(53.33%) Lymphocyte FASL 0(0%) 3(6.66%) 6(13.33%) 15(33.33%) 
control Tissue FASL 14(70%) 6(30%) 0(0%) 0(0%) 20(100%) Lymphocyte FASL 0(0%) 0(0%) 0(0%) 0(0%) 
Total no of CAG cases 45(100%) 
 
Table (6): Tissue versus lymphocytes insitu expression of FASL mRNA   in Cag A positive/Cag Anegative 
CAG    Patients and control group. 
 
Marker 
CD95L(FAS L) 
Cag Apositive Cag A negative T-Test 
p value 
Control 
group 
T-Test 
p value 
Tissue FASL 
mean ±  SE* 
21(46.66%) 
19.71±4.88 
24(53.33%) 
25±6.79 
p>0.05 3.3±0.66 p>0.05 
Lymphocyte FASL 
mean ±  SE* 
21(46.66%) 
78.57±8.51 
24(53.33%) 
51±6.47 
 
P<0.05 
ND* ND* 
p- value P<0.05 P<0.05  ND* ND* 
 
Table (7) : Correlations among tissue and cellular markers of CAG cases: 
 
Parameter Tissue Fas lymphocyte FAS 
Tissue 
FASL 
lymphocyte 
FASL CagA 
Lymphocyte grade 
r 0.409** -0.131 -0.283 -0.125 0.094 
P-value 0.005 0.391 0.059 0.412 0.537 
Tissue Fas 
r  0.116 -0.203 0.095 0.540** 
P-value  0.447 0.180 0.534 0.000 
Lymphocyte Fas 
r   -0.033 0.310* 0.511** 
P-value   0.831 0.038 0.000 
Tissue FasL 
r    0.075 -0.484** 
P-value    0.622 0.001 
Lymphocyte FasL 
r     0.390** 
P-value     0.008 
 
r = Pearson  Correlation 
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Discussion: 
      In the present study the prevalence of CAG among males and females was (73.3%) and (26.7%) respectively 
.This come in concordance  with that reported among  Canadian patients (44.1%) for males and (55.9%) for 
females (14) and Italian patients males represent (43.22%) and (56. 78%) were females(15). Others (16) were 
record high incidence of CAG among females (63%) compared with (37%) in males.  
         the possible reason for such difference may be related to study design which was an epidemiological study 
and focus on the prevalence of H.pylori infection in relation with gender and the size of community under 
investigation  that give a chance for difference in sample size of each gender type which is apparently  larger  in 
case of females in European  communities  .Emotional stress factor may have a role  in susceptibility  to H.pylori 
infection .Gender differences to H.pylori induced gastroduodenal diseases and  in disease susceptibility may 
reflect differences in immune responses, hormonal effects and sex linked genetic factors and differences in 
bacterial colonization (17) .The ability of H.pylori to induce CAG in the present study was related to several 
H.pylori related virulence factors that contribute in dissimilar ways in gastric mucosal damage. Among these 
factors are urease and flagella that known to be required for the colonization and survival of H. pylori in the 
human stomach. H. pylori manufacture large amounts of urease that helps to break down urea into carbon 
dioxide and ammonium, which neutralizes the acid during colonization of the stomach. Urease plays a dual role 
by making protection of H.pylori from gastric acid and induction of apoptosis in gastric cells as well as inhibits 
gastric somatostatin release in animals, which could alters the digestion physiology (18; 19).  
              The present study determine a significant correlation between  CAG induced by H.pylori CagApositive 
and the severity of lymphocytes infiltration in gastric mucosa and subsequently with the severity of atrophic 
changes  compared with CAG induced by H.pylori Cag Anegative ,that cause less extensive inflammatory 
changes in gastric mucosa  and this finding come in accordance with others (20 ; 21; 22) . The results of the 
present study give a primary indication about H.pylori vital role as we notice that there was obvious effect on the 
grade of FAS and FASL expression in gastric tissue and i lymphocytes infiltration among cases that harbored 
this pathogen in gastroduodenal biopsies compared with normal apparently healthy control. This could be related 
to several factors belongs to molecular interaction between pathogen and mucosal surface of its host. The 
production of CagA in the present study give an indication that H.pylori  poses an active Cag pathogenicity 
island encoding genes that may activate or even inhibit adherent factors which are utilized by H.pylori for its 
adhesion to the gastric epithelial cells possibly during the processes of adhesin synthesis, transportation, 
secretion and activation this collectively play a central role in the final scenario of interaction between gastric 
mucosa and H.pylori.  Whenever pathogen have potent Cag PAI, bacterial adhesion, and good signals will be 
received by the gastric epithelial cells which reflect its response by increasing MHCII expression to play as 
antigen presenting cell and strong Th1 response will be occur with obvious IFNγ secretion which act as good 
stimulator for up-regulation of FAS and even FASL in gastroduodenal tissue (GDT) and tissue infiltrating 
lymphocytes (TILs)(23).  
    In the present study in CAG  ,CagA positive H. pylori –infected mucosa ,the expression of CD95 and CD95L  
was upregulated in surface epithelium, lamina propria lymphocytes with significant differences recorded 
Figure (1): 
A) In situ hybridization for CagA Positive H.pylori in gastric 
tissue section .staining by BCIP/NBT (bluish purple) 
counterstained with nuclear fast red. Bar size=50µm. 
B) negative expression .Bar size=50µm. 
C) In situ hybridization for human Fas in gastric atrophy 
tissue section mainly in gastric glands and inflammatory cell 
infiltrates  staining by BCIP/NBT (bluish purple) 
counterstained with nuclear fast red. Bar size=50µm. 
D) In situ hybridization for human FasL in gastric atrophy 
tissue section .staining by BCIP/NBT (bluish purple) 
counterstained with nuclear fast red. Bar size=50µm. 
D C 
D 
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between gastric tissue and infiltrating lymphocytes as well as between  CagApositive  and CagAnegative  
infected gastric tissue   and this   come in accordance with studies around the world (24,25,26,27), increased 
levels of CD95L mRNA found by insitu in lamina propria cells suggest that lymphocytes in the lamina propria 
express CD95L and induce apoptosis via CD95L in CD95-positive neighboring cells.  
             Expression of Fas and FasL in gastric tissue and infiltrating lymphocytes support our opinion that 
apoptosis of gastric epithelial cell not only induced by CD95L-expressing lymphocytes but also by CD95L-
expressing epithelial cells. CD95L expressed on gastric epithelial cells in a membrane-bound form mediate 
apoptosis by “fratricide” interacting with CD95 on adjacent epithelial cells as well as through suicide of the 
CD95L-CD95–expressing cell itself  . Upregulation of Fas-FasL in gastric tissue may be related to the cytokine  
microenvironment or H.pylori  factors other than Cag and Vac .This opinion was come in agreement with ( 
28,29,30) they stated that CagA producing H. pylori strains are associated with increased Th1 cytokines 
production in the gastric mucosa and in gastric epithelial cell lines, Among these inflammatory cytokines, IL-1, 
IL-2, TNF-α, and IFNγ that have been shown to up-regulate the expression of Fas Ag in cell lines and in 
gastroduodenal biopsies. IFNγ and TNF- α, and H. pylori infection activate transcription factors in gastric 
epithelial cells that bind to the NF-kB and AP-1 regulatory sites (30,31) Since these regulatory sites are located 
in the 59 region of the Fas gene, it is possible that both can contribute to the induction of Fas expression that 
were studied using ISH detection technique (32 ). However, our results showed that H. pylori strain, which 
lacks the cag PAI, induced Fas expression, although to a lesser degree. Th1 cytokines can not only injure the 
gastric epithelium directly (33,34 ) but also accelerate epithelial damage by modulating Fas/FasL interactions  
(35;36). 
         The frequency of epithelial apoptosis found to be significantly lower in noninflamed gastric mucosa. 
Mannick, et al., (1996)(37) agree with result of the present study, they describe increased apoptosis of epithelial 
cells in the neck region of the gastric glands that decreased after eradication therapy in H. pylori-infected 
subjects. The presence of apoptotic epithelial cells suggests that the epithelial barrier may be compromised. 
This could contribute to increased permeability and a breakdown in the cytoprotective mechanisms that guard 
the epithelium against damage to luminal acid and pepsin. Studies of (38,39 ) were giving bright evidence about 
the role of H.pylori infection in apoptosis induction of gastric epithelial cells. They found a significant increase 
in apoptotic index only in H.pylori infected subjects, in comparison to uninfected subjects. However, these 
studies did not examine the effects of H. pylori CagA positive and CagAnegative strains separately. In brief the 
results of (34,38, 39 ) which represent a results from different area around the world come in agreement with 
the results of the present study give a supportive evidence about the main role of Cag A positive H.pylori in 
apoptosis induction of gastric epithelial cells. The possible reason for differences between the results of the 
present study and other conflicting studies might be related to study design. Our study strategy depends on the 
comparative evaluation of the possible effect of CagApositive H.pylori on CAG cases compared with normal 
apparently healthy volunteers, other conflicted clinical studies like study of (40) who depends on the single 
clinical presentation type, which is chronic gastritis, beside differences in population under focus, ethnic 
groups, and geographical area of the study.  
        In Conclusions, FAS-FASL pathway play vital role in Immunopathology of H.pylori Cag A+ associated 
gastritis that leads finally to atrophic changes. 
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